PUBLIC PREDICTION RECEIPT
OTR predicted SPDR S&P Biotech ETF would rise
1f9546783ee3a3ff9a88c59674596ce5eebba7f6ee8475cbb11f849e2575e8a5
- Asset
- SPDR S&P Biotech ETF · XBI
- Direction
- UP
- Created
- Deadline
- Entry
- 157.41 USD
- Deadline price
- Checking…
- Raw return
- Checking…
- Relevant market return
- Checking…
- Market-adjusted result
- Checking…
- Original recorded result
- Not yet graded —
- Scientific event verdict
- Inconclusive until all required evidence passes
- Record status
- Original prediction cannot be secretly changed
Original frozen reason
Current asset- or exposure-aligned headlines are directionally neutral under the disclosed lexicon. Pavuron keeps the locked research disposition BULLISH without claiming that headlines prove a rise.
Invalidation condition
A later evidence reversal may change the next edition, but it cannot rewrite this score. The source-timed +20-hour check remains the only outcome authority.
Calculating synchronized evidence without changing the Original recorded result.
Sources, hashes and audit history
- Prediction row hash
- 75a6c074c16d5d4b4203d0428c52f599be27ca49ae0ce99c9f3f4e16a3793ea0
- Prediction receipt hash
- 1f9546783ee3a3ff9a88c59674596ce5eebba7f6ee8475cbb11f849e2575e8a5
- Outcome append hash
- Pending or unavailable
- Model / method
- OTR-PAVURON-INVESTMENT-SCORE-V3 · OTR-EVENT-STUDY-FAIL-CLOSED-C49-V1
Each original result retains its original rules and cohort. Market-adjusted measurements do not regrade it. A saved imported row does not by itself establish membership in the separate historical founder score.